Ayinde O. Chase - All Headline News Staff Writer
Dallas, TX (AHN) - Shire Pharmaceuticals Inc. unveils new data demonstrating highly prescribed children' drug Adderall significantly improves symptoms in adults with attention deficit-hyperactivity disorder (ADHD).
Nearly 75-percent of study participants experienced improvement in ADHD symptoms, according to preliminary results of the Quality of Life, Effectiveness, Safety, and Tolerability (Qu.E.S.T.) study, presented the data at the annual meeting of Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD).
Qu.E.S.T. Investigator David Goodman, M.D., director of the Adult Attention Deficit Disorder Center of Maryland, Lutherville, Maryland says, "Qu.E.S.T. is the largest study of its kind to date to document improvements in symptoms of adult ADHD. The good news for adults with ADHD is that Adderall XR was shown to improve ADHD symptoms and was also generally well tolerated."
Qu.E.S.T. is a 30-week, open-label, multicenter investigation of adults, aged 18 and older, diagnosed with ADHD who receive treatment with once-daily Adderall XR.
This study was conducted in community practice settings at 74 U.S. and seven Canadian sites. The most commonly reported drug-related adverse events in Qu.E.S.T. were generally mild and included decreased appetite, headache, dry mouth and insomnia. The last paragraph sounds just like caffeine. The obvious differences are not posted here? No control group is cited in doc.But well worth mentioning,thanks.i'm sure that there would be a control group.. they just probably thought that we wouldn't understand the term and process of it all [QUOTE=repairman] The last paragraph sounds just like caffeine. The obvious differences are not posted here? No control group is cited in doc.But well worth mentioning,thanks.[/QUOTE]